Partnership combines Lunit’s platform-agnostic AI pathology algorithms with CellCarta’s global CDx development and laboratory execution to help biopharma teams de-risk assets…
Company’s first-ever share buyback program underscores management and the Board’s confidence in UMG’s strategy and long-term growth HILVERSUM, The Netherlands,…
Acquisition launches accesso IntelligenceSM, connecting guest and operator data, insight and action across the entire operation ORLANDO, Fla., March 30,…